Aida Salehi
Montreal,Canada
Summary
Professional with experience in clinical research coordination, equipped to make significant impact in this field. Demonstrated ability to manage clinical trials, ensure compliance with protocols, and maintain accurate documentation. Strong emphasis on team collaboration, reliability, and adaptability to evolving project requirements. Proficient in patient recruitment, data collection, and regulatory submissions, with results-driven approach that ensures successful study outcomes.
Overview
3
3
years of professional experience
Work History
Clinical Research Coordinator and Data Manager
Jewish General Hospital, Lady Davis Institute
05.2022 - Current
- Coordinate phase II, III Clinical trials on breast cancer, prostate cancer, and Nuclear Medicine studies
- Recruit research participants, prescreen patients and obtain informed consents, assess patients for protocol eligibility through personalized interviews and medical records review in in-patient and out-patient settings
- Maintain and complete medication, adverse events, and questionnaire logs, forms, and protocol-specific source documentation to ensure ethical approvals are continued throughout the study
- Monitor patient safety and medication compliance
- Coordinate all aspects of data collection and source documentation
- Collaborate with the Monitor, the Quality Assurance, and any resource assigned to the oncology team
- Pre-screened more than 500 breast cancer patients
- Screened more than 100 patients and recruited 70 participants in 7 protocols over 3 years
- Excellent communication with oncology patients and their families to increase motivation to follow the study schedules, and better participation
- Maintained and completed concomitant medication, adverse event, RECIST 1.1 logs
Clinical Research Assistant
Jewish General Hospital
10.2021 - 04.2024
- Reviewed charts and gathered data, including pathology and molecular testing reports of patients with metastatic prostate cancer
- Analyzed data
- Published two abstracts in the American Society of Clinical Oncology Journal
- Resulted in three poster presentations at ASCO GU 2024, 2025, and CORTO 2024
- Reviewed charts and gathered data, including pathology reports of biopsy and surgery of patients with HER2-positive breast cancer
- Reviewed literature related to non metastatic HER2-positive breast cancer
- Published a pathology-oncology-related article in Breast Cancer Research and Treatment
Education
Graduate Diploma - Oncology
McGill University
Montreal, QC05.2024
Medical Doctor (M.D) -
Shiraz University of Medical Sciences (SUMS)
01.2018
Skills
- EMRs (Endovault, chartmaxx, Oacis)
- Critical thinking
- Multi-tasking
- Time management
- Teamwork
- Emotional intelligence
- Stress management
- Detailed and Organized
- Microsoft Office
- Imedidata Rave
- Inform and Veeva vault
- AG mednet
- Planning and coordination
- Project presentation
- Interpersonal communication
- Good clinical practices
- Clinical data management
- Electronic data capture
- Adverse event reporting
- Ethics protocol adherence
- Research experience
- Adverse event tracking
- Problem-solving
- Teamwork and collaboration
- Conflict resolution
- Organizational skills
- Protocol review
- Written communication
- Detailed documentation
Languages
English
Full Professional
Persian
Native or Bilingual
French
Limited Working
Timeline
Clinical Research Coordinator and Data Manager
Jewish General Hospital, Lady Davis Institute
05.2022 - Current
Clinical Research Assistant
Jewish General Hospital
10.2021 - 04.2024
Medical Doctor (M.D) -
Shiraz University of Medical Sciences (SUMS)
Graduate Diploma - Oncology
McGill University
Publications
- Role of liquid biopsy in the detection of Homologous Recombination Repair Gene Mutations (HRRm) in Metastatic Prostate Cancer (mPC), Labidi S, Fallah P, Salehi Nobandegani A, Rajan R, Alameldin M, Brimo F, Foulkes W, Papadakis A, Spatz A, Ferrario C, Saleh R, Rose A, American Society of Clinical Oncology Journal, 2025
- Preoperative factors that predict pathologic nodal involvement in early stage HER2+ breast cancer: Selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery, Faleh S, Prakash I, Salehi Nobandegani A, Khan H, Basik M, Boileau JF, Tejera D, Panet F, Meterissian S, Wong S, Breast Cancer Research and Treatment, 2024, 205, 1, 303-312, https://doi.org/10.1007/s10549-024-07251-8
- Clinical outcomes with systemic therapy given after progression on prostate specific membrane antigen radioligand therapy (PSMA-RLT) in patients with metastatic castration-resistant prostate cancer (mCRPC), Labidi S, Salehi Nobandegani A, Fallah P, Morin V, Li M, Probst S, Ferrario C, Rose A, American Society of Clinical Oncology Journal, 2024, 42, 4, 78, https://doi.org/10.1200/JCO.2024.42.4_suppl.78
Similar Profiles
Kelli DimayugaKelli Dimayuga
Clinical Trials Coordinator & Administrative Lead at Lady Davis Institute, Jewish General HospitalClinical Trials Coordinator & Administrative Lead at Lady Davis Institute, Jewish General Hospital
Ana Luiza Abdalla dos SantosAna Luiza Abdalla dos Santos
Immuno-virology Researcher at McGill University/ Lady Davis Institute- Jewish General HospitalImmuno-virology Researcher at McGill University/ Lady Davis Institute- Jewish General Hospital
ÉRIKA CRISTINA DOS SANTOSÉRIKA CRISTINA DOS SANTOS
Postdoctoral Fellowship at Lady Davis Institute for Medical Research at Jewish HospitalPostdoctoral Fellowship at Lady Davis Institute for Medical Research at Jewish Hospital
Fabricio CadenaFabricio Cadena
Credit Analyst at Credit Risk ManagementCredit Analyst at Credit Risk Management
Watta Kenneth COMPAOREWatta Kenneth COMPAORE
IT Technician Intern at Les Solutions BlackIP 360 Inc/CyberVision247 IncIT Technician Intern at Les Solutions BlackIP 360 Inc/CyberVision247 Inc